Braidwell LP Day One Biopharmaceuticals, Inc. Call Options Transaction History
Braidwell LP
- $1.63 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DAWN
# of Institutions
188Shares Held
69.3MCall Options Held
127KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$47.6 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$45.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$33.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$30.4 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$27.6 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $544M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...